Ai X - Search Results

1

Tislelizumab Plus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC (RATIONALE 304): A Randomized Phase 3 Trial.

Lu S, Wang J, Yu Y, Yu X, Hu Y, Ai X, Ma Z, Li X, Zhuang W, Liu Y, Li W, Cui J, Wang D, Liao W, Zhou J, Wang Z, Sun Y, Qiu X, Gao J, Bao Y, Liang L, Wang M. Lu S, et al. Among authors: ai x. J Thorac Oncol. 2021 Sep;16(9):1512-1522. doi: 10.1016/j.jtho.2021.05.005. Epub 2021 May 23. J Thorac Oncol. 2021. PMID: 34033975 Free article. Clinical Trial.

2

Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.

Li Z, Yu Y, Lu J, Luo Q, Wu C, Liao M, Zheng Y, Ai X, Gu L, Lu S. Li Z, et al. Among authors: ai x. J Thorac Oncol. 2009 Jun;4(6):702-9. doi: 10.1097/JTO.0b013e3181a5269d. J Thorac Oncol. 2009. PMID: 19404215 Free article.

3

[Genome wide association study on lung cancer.].

Niu X, Ai X, Lu S. Niu X, et al. Among authors: ai x. Zhongguo Fei Ai Za Zhi. 2009 Jul 20;12(7):792-8. doi: 10.3779/j.issn.1009-3419.2009.07.010. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719158 Free article. Chinese. No abstract available.

4

[Advances of maintenance chemotherapy on advanced non-small cell lung cancer.].

Ai X, Lu S. Ai X, et al. Zhongguo Fei Ai Za Zhi. 2008 Feb 20;11(1):14-6. doi: 10.3779/j.issn.1009-3419.2008.01.004. Zhongguo Fei Ai Za Zhi. 2008. PMID: 20727258 Free article. Chinese. No abstract available.

5

Establishment of a biomarker model for predicting bone metastasis in resected stage III non-small cell lung cancer.

Zhou Z, Chen ZW, Yang XH, Shen L, Ai XH, Lu S, Luo QQ. Zhou Z, et al. J Exp Clin Cancer Res. 2012 Apr 26;31(1):34. doi: 10.1186/1756-9966-31-34. J Exp Clin Cancer Res. 2012. PMID: 22537906 Free PMC article.

6

Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients.

Yang Y, Zhou Z, Niu XM, Li ZM, Chen ZW, Jian H, Ai XH, Cheng BJ, Liao ML, Lu S. Yang Y, et al. J Surg Oncol. 2012 Nov;106(6):736-41. doi: 10.1002/jso.23190. Epub 2012 Jun 18. J Surg Oncol. 2012. PMID: 22711667

7

Long-term survival in thymic epithelial tumors: a single-center experience from China.

Shen S, Ai X, Lu S. Shen S, et al. Among authors: ai x. J Surg Oncol. 2013 Feb;107(2):167-72. doi: 10.1002/jso.23256. Epub 2012 Sep 20. J Surg Oncol. 2013. PMID: 22996015

8

A systematic profile of clinical inhibitors responsive to EGFR somatic amino acid mutations in lung cancer: implication for the molecular mechanism of drug resistance and sensitivity.

Ai X, Sun Y, Wang H, Lu S. Ai X, et al. Amino Acids. 2014 Jul;46(7):1635-48. doi: 10.1007/s00726-014-1716-0. Amino Acids. 2014. PMID: 24658966

9

Formononetin suppresses the proliferation of human non-small cell lung cancer through induction of cell cycle arrest and apoptosis.

Yang Y, Zhao Y, Ai X, Cheng B, Lu S. Yang Y, et al. Among authors: ai x. Int J Clin Exp Pathol. 2014 Dec 1;7(12):8453-61. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25674209 Free PMC article.

10

NF-κB-mediated miR-124 suppresses metastasis of non-small-cell lung cancer by targeting MYO10.

Sun Y, Ai X, Shen S, Lu S. Sun Y, et al. Among authors: ai x. Oncotarget. 2015 Apr 10;6(10):8244-54. doi: 10.18632/oncotarget.3135. Oncotarget. 2015. PMID: 25749519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,386 results

Search Page

Filters